Impact of adherence and weight loss on glycemic control in patients with type 2 diabetes: cohort analyses of integrated medical record, pharmacy claims, and patient-reported data.

@article{McAdamMarx2014ImpactOA,
  title={Impact of adherence and weight loss on glycemic control in patients with type 2 diabetes: cohort analyses of integrated medical record, pharmacy claims, and patient-reported data.},
  author={Carrie McAdam-Marx and Brandon Kyle Bellows and S. Aravind Unni and Gail Wygant and Jayanti Mukherjee and Xiangyang Ye and Diana I. Brixner},
  journal={Journal of managed care & specialty pharmacy},
  year={2014},
  volume={20 7},
  pages={691-700}
}
BACKGROUND Managed care organizations put great effort into managing the population of patients with type 2 diabetes mellitus (T2DM) because of the health and economic burden of this disease. In patients with T2DM, weight loss and glycemic control are primary treatment aims to help improve patient outcomes, but these goals are not easily achieved. While achieving these aims requires a multifaceted approach of drug therapy management and lifestyle modification, truly understanding the role of… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

Real-world evidence in pain research: a review of data sources.

Journal of pain & palliative care pharmacotherapy • 2014

References

Publications referenced by this paper.
Showing 1-10 of 41 references

Dapagliflozin for the treatment of type 2 diabetes.

Expert opinion on pharmacotherapy • 2013
View 1 Excerpt

Similar Papers

Loading similar papers…